In Ang II-induced hypertension rats, a blockade of TLR4 delayed the progression of hypertension and reduced the TNF-α and IL-1β levels and NF-κB activity in myocardial tissue, which improved cardiac hypertrophy [13]. The gene discussed is NFKB1; the disease is cardiac hypertrophy.